OptimizeRx Corp [OPRX] stock is trading at $4.87, up 8.46%. An important factor to consider is whether the stock is rising or falling in short-term value. The OPRX shares have gain 27.32% over the last week, with a monthly amount drifted -10.48%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, JMP Securities started tracking the stock with Mkt Outperform rating on April 04, 2024, and set its price target to $15. On January 03, 2024, Barclays initiated with a Equal Weight rating and assigned a price target of $15 on the stock. Stifel initiated its recommendation with a Buy and recommended $19 as its price target on November 01, 2022. SVB Leerink started tracking with a Outperform rating for this stock on July 15, 2022, and assigned it a price target of $38.
OptimizeRx Corp [OPRX] stock has fluctuated between $3.78 and $16.65 over the past year. Currently, Wall Street analysts expect the stock to reach $15 within the next 12 months. OptimizeRx Corp [NASDAQ: OPRX] shares were valued at $4.87 at the most recent close of the market. An investor can expect a potential return of 208.01% based on the average OPRX price forecast.
Analyzing the OPRX fundamentals
OptimizeRx Corp [NASDAQ:OPRX] reported sales of 88.18M for the trailing twelve months, which represents a growth of 30.48%. Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at -0.32%, Pretax Profit Margin comes in at -0.38%, and Net Profit Margin reading is -0.27%. To continue investigating profitability, this company’s Return on Assets is posted at -0.15, Equity is -0.2 and Total Capital is -0.19. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.55 points at the first support level, and at 4.23 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.11, and for the 2nd resistance point, it is at 5.34.
Ratios To Look Out For
For context, OptimizeRx Corp’s Current Ratio is 3.23. On the other hand, the Quick Ratio is 3.23, and the Cash Ratio is 1.11. Considering the valuation of this stock, the price to sales ratio is 1.10, the price to book ratio is 0.78.
Transactions by insiders
Recent insider trading involved Odence-Ford Marion, General Counsel and CCO, that happened on Jan 09 ’24 when 4000.0 shares were sold.
